2022 CANTAB Research Grant: Assessing Chemotherapy-Related Cognitive Impairment (CRCI)
Insights Back to resource centre 18 October 2022 2022 CANTAB Research Grant: Assessing Chemotherapy-Related Cognitive Impairment (CRCI) We caught up with 2022 CANTAB Research Grant winner Peter Mukli, who tells us about how the grant will enable him and his team to investigate the impact of chemotherapy on cognition in breast cancer survivors. I am originally from Hungary and obtained
2022 CANTAB Research Grant: Assessing Chemotherapy-Related Cognitive Impairment (CRCI) Read More »